DETECTING AND TREATING OVARIAN CANCER EARLY
Early detection of ovarian cancer improves patient outcomes. Developing an efficient test capable of accurately detecting ovarian cancer in its earliest stage will be a major advancement.
Utilization of Bcl-2 as a diagnostic marker facilitates the creation of a highly specific and sensitive ovarian cancer test which will enable detection and intervention in the critical early stages of the malignancy.
Accessibility and affordability of a Point-of-Care test will further ensure more frequent testing and hence increase the rate of detection and offer superior monitoring of disease status.